16-2148823-A-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014353.5(RAB26):āc.40A>Cā(p.Thr14Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000149 in 1,409,562 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_014353.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000199 AC: 3AN: 150800Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000139 AC: 1AN: 72000Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 42378
GnomAD4 exome AF: 0.0000143 AC: 18AN: 1258762Hom.: 0 Cov.: 31 AF XY: 0.00000646 AC XY: 4AN XY: 619516
GnomAD4 genome AF: 0.0000199 AC: 3AN: 150800Hom.: 0 Cov.: 32 AF XY: 0.0000136 AC XY: 1AN XY: 73656
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 08, 2022 | The c.40A>C (p.T14P) alteration is located in exon 1 (coding exon 1) of the RAB26 gene. This alteration results from a A to C substitution at nucleotide position 40, causing the threonine (T) at amino acid position 14 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at